Lv3
360 积分 2025-01-03 加入
稳中求进
Immune modulating activity of the CHK1 inhibitor prexasertib and anti-PD-L1 antibody LY3300054 in patients with high-grade serous ovarian cancer and other solid tumors
18天前
已完结
Targeting transcription factors in cancer — from undruggable to reality
23天前
已完结
Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors
1个月前
已完结
A patent review of CHK1 inhibitors (2019 – present)
1个月前
已完结
Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity
1个月前
已完结
Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors
1个月前
已完结
Bicyclic Imidazolium Inhibitors of Gli Transcription Factor Activity
1个月前
已完结
Review article: the clinical pharmacology of proton pump inhibitors
1个月前
已完结
Prodrugs for ocular diseases
2个月前
已完结
皖公网安备34019202002308
